{
  "resourceType": "Medication",
  "id": "mii-exa-test-data-medication-dalbavancin",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/Medication"
    ]
  },
  "code": {
    "coding": [
      {
        "system": "http://fhir.de/CodeSystem/ifa/pzn",
        "code": "06312077",
        "display": "ASS 100 - 1a Pharma TAH Tabletten"
      },
      {
        "system": "http://fhir.de/CodeSystem/bfarm/atc",
        "code": "J01XA04",
        "version": "2023",
        "display": "Dalbavancin"
      }
    ]
  },
  "form": {
    "coding": [
      {
        "system": "http://standardterms.edqm.eu",
        "code": "50043000",
        "display": "Powder for concentrate for solution for infusion"
      }
    ]
  },
  "ingredient": [
    {
      "itemCodeableConcept": {
        "coding": [
          {
            "system": "http://fhir.de/CodeSystem/ask",
            "code": "33395",
            "display": "Dalbavancin"
          },
          {
            "system": "http://fdasis.nlm.nih.gov",
            "code": "808UI9MS5K"
          },
          {
            "system": "urn:oid:2.16.840.1.113883.6.61",
            "code": "171500-79-1"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "703917001",
            "version": "http://snomed.info/sct/900000000000207008/version/20230731",
            "display": "Dalbavancin (substance)"
          }
        ]
      }
    }
  ]
}
